The company producing 155 million new doses of smallpox vaccine for the United States says it won’t use a stem cell line taken from an aborted fetus. The announcement represents a reversal of earlier plans. The U.S. Department of Health and Human Services contracted with Acambis PLC of Great Britain to manufacture smallpox vaccine to be stockpiled against the danger…